Clinical Trial Update: MLN9708 (Ixazomib) in Combination With Panobinostat and Dexamethasone in Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of Ixazomib (MLN9708) in combination with panobinostat and dexamethasone for multiple myeloma has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Panobinostat (Panobinostat)
• ixazomib (ixazomib)

Snippet

Sponsor: Jason Valent | Conditions: Multiple Myeloma, Kahler Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-12-11